The effects of TREM-1 and TLR-4 inhibition on early vessel thrombosis was under investigation because pro-inflammatory mediators TREM-1 and TLR-4 play a critical role in atheromatous plaque formation, atherosclerosis, and vessel stenosis [11,12,13,14]. Here, TLR4 is linked to atherosclerosis.